| Code | 2187D | ||||||||||
| MA number | 44/0235/19-S | ||||||||||
| Product Form: | plc fol 1x100 mg + 1x3 ml solv. (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva k.s., Czechia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 19.07.2019 |
| Pediatric contraindication: | Yes |
| SPC: |
SPC_Carmustine Zentiva 100 mg_03.2025.pdf
|
| PIL: |
PIL_Carmustine Zentiva 100 mg_03.2025.pdf
|
| Safety feature | Yes |
| Data update: | 18.04.2024 |
